- Home
- FLNT vs ATRA Comparison
FLNT vs ATRA Comparison
Compare FLNT & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLNT
- ATRA
- Stock Information
- Founded
- FLNT 2010
- ATRA 2012
- Country
- FLNT United States
- ATRA United States
- Employees
- FLNT N/A
- ATRA N/A
- Industry
- FLNT Advertising
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FLNT Consumer Discretionary
- ATRA Health Care
- Exchange
- FLNT Nasdaq
- ATRA Nasdaq
- Market Cap
- FLNT 49.6M
- ATRA 50.3M
- IPO Year
- FLNT N/A
- ATRA 2014
- Fundamental
- Price
- FLNT $2.82
- ATRA $12.00
- Analyst Decision
- FLNT Hold
- ATRA Hold
- Analyst Count
- FLNT 1
- ATRA 5
- Target Price
- FLNT $4.00
- ATRA $26.88
- AVG Volume (30 Days)
- FLNT 13.0K
- ATRA 139.6K
- Earning Date
- FLNT 11-14-2024
- ATRA 11-12-2024
- Dividend Yield
- FLNT N/A
- ATRA N/A
- EPS Growth
- FLNT N/A
- ATRA N/A
- EPS
- FLNT N/A
- ATRA N/A
- Revenue
- FLNT $261,976,999.00
- ATRA $100,439,000.00
- Revenue This Year
- FLNT N/A
- ATRA $1,190.80
- Revenue Next Year
- FLNT $13.16
- ATRA N/A
- P/E Ratio
- FLNT N/A
- ATRA N/A
- Revenue Growth
- FLNT N/A
- ATRA 2111.34
- 52 Week Low
- FLNT $2.31
- ATRA $6.50
- 52 Week High
- FLNT $4.80
- ATRA $39.50
- Technical
- Relative Strength Index (RSI)
- FLNT 42.92
- ATRA 59.39
- Support Level
- FLNT $2.91
- ATRA $11.10
- Resistance Level
- FLNT $3.20
- ATRA $14.93
- Average True Range (ATR)
- FLNT 0.15
- ATRA 1.41
- MACD
- FLNT -0.01
- ATRA 0.26
- Stochastic Oscillator
- FLNT 2.51
- ATRA 53.64
About FLNT Fluent Inc.
Fluent Inc is a data-driven digital marketing services company. It performs customer acquisition services by operating digital marketing campaigns, through which it connects its advertiser clients with consumers they are seeking to reach. It delivers data and performance-based marketing executions to its clients, such as consumer brands, direct marketers and agencies across a wide range of industries, including Financial Products & Services, Media & Entertainment, Health & Wellness, Staffing & Recruitment and Retail & Consumer.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).